entertainment -WSS

entertainment

author：focus 2025-08-12 08:25:58 - browse：48

WASHINGTON — A White House task force created to work on drug shortage reforms has yet to contact the lawmakers who are writing legislation to stem shortages — and it’s not clear when the task force will recommend policies.

The White House formed a task force at the beginning of 2023 to deal with the issue of persistent drug shortages. Fifty-seven percent of hospital pharmacists said they are facing critical shortages of chemotherapy drugs in a new survey from the American Society of Health-System Pharmacists. Hospital pharmacists also reported significant shortages of steroids, hormonal drugs, and oral liquids such as amoxicillin and lidocaine.

Yet industry and patient representatives who have met with task force members said there has been no indication of when they will make recommendations that could spur federal agencies to act and steer the debate in Congress.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

WSS

Telehealth for opioid use disorder is lifesaving

What affirmative action's end means to a medical student

IRA could hurt research into orphan drugs for rare diseases

Regeneron agrees to White House price limits on anti

Prescription digital therapeutics are key to pharma’s future

Security flaws in third

entertainment

entertainment

knowledge

The cancer drug shortage isn’t new — and neither are the solutions

Dexcom's push to bring CGM to type 2 diabetes patients

How to save PrEP access — and even expand it

Regeneron agrees to White House price limits on anti

Duchenne breakthrough therapy leaves behind pioneering families

Will the IRA bring competition to the biologics market?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

White House touts steps to stem shortages of cancer treatments

Duchenne breakthrough therapy leaves behind pioneering families

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

hotspot

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

What affirmative action's end means to a medical student

Dexcom's push to bring CGM to type 2 diabetes patients

Walmart eyes Medicare Advantage provider ChenMed

What to make of Biden’s latest efforts on cancer research

WATCH: Why do bright lights make us see spots?

hotspot

explore

hotspot

leisure time